Evidence map›Paper›PMID 31263983›Full record

ArticleEuropean journal of nutrition2020

Synergistic and antagonistic interactions between antibiotics and synbiotics in modifying the murine fecal microbiome.

Angela Jačan, Karl Kashofer, Geraldine Zenz, Esther E Fröhlich, Florian Reichmann, Ahmed M Hassan, Peter Holzer

Abstract read
In one paragraph

Article in European journal of nutrition, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Angela JačanCBmed GmbH-Center for Biomarker Research in Medicine, Stiftingtalstrasse 5, 8010, Graz, Austria.ORCID http://orcid.org/0000-0002-3269-0208
Karl KashoferDiagnostic and Research Institute of Pathology, Diagnostic and Research Center of Molecular Biomedicine, Medical University of Graz, Neue Stiftingtalstrasse 6, 8010, Graz, Austria.ORCID http://orcid.org/0000-0002-5803-4014
Geraldine ZenzResearch Unit of Translational Neurogastroenterology, Division of Pharmacology, Otto Loewi Research Center, Medical University of Graz, Universitätsplatz 4, 8010, Graz, Austria.ORCID http://orcid.org/0000-0003-3611-8724
Esther E FröhlichResearch Unit of Translational Neurogastroenterology, Division of Pharmacology, Otto Loewi Research Center, Medical University of Graz, Universitätsplatz 4, 8010, Graz, Austria.ORCID http://orcid.org/0000-0001-6985-0642
Florian ReichmannResearch Unit of Translational Neurogastroenterology, Division of Pharmacology, Otto Loewi Research Center, Medical University of Graz, Universitätsplatz 4, 8010, Graz, Austria.ORCID http://orcid.org/0000-0002-5833-3698
Ahmed M HassanResearch Unit of Translational Neurogastroenterology, Division of Pharmacology, Otto Loewi Research Center, Medical University of Graz, Universitätsplatz 4, 8010, Graz, Austria.ORCID http://orcid.org/0000-0003-1389-9599
Peter HolzerResearch Unit of Translational Neurogastroenterology, Division of Pharmacology, Otto Loewi Research Center, Medical University of Graz, Universitätsplatz 4, 8010, Graz, Austria. peter.holzer@medunigraz.at.ORCID http://orcid.org/0000-0002-5754-395X

Funding

Austrian Science Fund FWF P 25912Österreichische Forschungsförderungsgesellschaft CBmedÖsterreichischer Wissenschaftsfonds (FWF) P25912-B23Österreichischer Wissenschaftsfonds (FWF) W1241-B18
6 · The paper itself

Abstract

purposePro- and synbiotics have been reported to ameliorate the adverse (dysbiotic) effects of antibiotics on the gut microbial architecture, but little is known how synbiotics and antibiotics interact with each other in shaping the gut microbiota. To explore this mutual interaction we examined, first, the effect of a multi-strain synbiotic on antibiotic-induced dysbiosis and, second, the dysbiotic effect of antibiotics followed by prolonged synbiotic exposure.

methodsThe synbiotic containing nine bacterial strains was administered to male mice via the drinking water, while the antibiotic mix containing bacitracin, meropenem, neomycin, and vancomycin was administered via oral gavage. Two experimental protocols were used. In protocol 1, mice were administered placebo or synbiotic for 3 weeks prior to and during an 11-day vehicle or antibiotic treatment. In protocol 2 the synbiotic was administered for a prolonged period of time, starting 3 weeks prior and continuing for 12 weeks after an 11-day vehicle or antibiotic treatment. Subsequently, the fecal microbiome was analyzed by 16S rRNA sequencing using oligonucleotide primers 16s_515_S3_fwd: GATTGCCAGCAGCCGCGGTAA and 16s_806_S2_rev: GGACTACCAGGGTATCTAAT followed by sequencing using the Ion Torrent One. The final sequence files were analyzed by QIIME 1.8 workflow scripts.

resultsAntibiotic treatment markedly decreased the bacterial richness and diversity of the fecal microbiota. Synbiotic administration for 3 weeks prior to and during an 11-day antibiotic treatment preserved the Lactobacillales and expanded the Verrucomicrobiales and Bifidobacteriales order, but did not prevent the depletion of Bacteroidales and the short-term proliferation of Enterobacteriales. When the synbiotic administration was continued for 12 weeks after the end of antibiotic treatment, the rise of Verrucomicrobiales was maintained, whereas the preservation of Lactobacillales and boost of Bifidobacteriales was lost. The abundance of Clostridiales was enhanced by long-term synbiotic treatment after short-term exposure to antibiotics, while the antibiotic-depleted Bacteroidales underwent a delayed recovery.

conclusionsThere are complex synergistic and antagonistic interactions of synbiotics and antibiotics in influencing distinct bacterial orders of the fecal microbiota. The impact of a short-term antibiotic exposure is profoundly different when analyzed after synbiotic pretreatment or following prolonged synbiotic administration in the post-antibiotic period.

Indexed as

MicrobiotaSynbioticsAnimalsAnti-Bacterial AgentsFecesMaleMiceRNA, Ribosomal, 16SAnti-Bacterial AgentsRNA, Ribosomal, 16SAntibioticsBacterial diversityBacterial ordersBacterial richnessGut microbiotaRecovery from antibiotic treatmentSynbiotics

Identifiers

PMID31263983
PMCPMC7351849

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.